CRISPR discovery opens up new possibilities for genetic engineering

CRISPR has frequently made headlines in recent years as scientists develop it to address some of the medical sector’s most pressing challenges. However, most of the advancements that have been made in this area have been due to applications of the CRISPR-Cas9 gene-editing tool, but scientists have emphasized that this is just a small portion of the total potentiality achievable with CRISPR.

Now, scientists at North Carolina’s Duke University have successfully developed a different kind of CRISPR technology, which not only has added to the toolbox of genetic engineering devices, but has also opened up a world of possibility to future developments in the genetic engineering space.

CRISPR Cas-9Meletios Verras | Shutterstock

Class 1 has been overlooked

What biomedical engineers have achieved at Duke is the demonstration that Class 1 CRISPR systems that have until now been largely unexplored can, in fact, be successfully utilized in editing genomes in human cells. The impact of the new research into Class 1 CRISPR systems is expected to inaugurate an entirely new sector of gene engineering technology.

Class 1 vs class 2

For years, scientists have worked on developing methods to exploit the CRISPR-Cas system in order to target and edit DNA in human cells. Naturally, it is a defense system where CRISPR-associated (Cas) proteins together with RNA molecules are used by bacteria to specifically target and eradicate the DNA of an infecting virus.

Numerous applications that have harnessed the mechanisms of this system have mostly focused on the Cas-9 system, which is a class 2 system. Cas-9 has been shown on numerous occasions to be able to successfully edit human DNA by cutting it at the targeted location, and once cut, genetic material can be added or deleted.

Surprisingly, class 2 systems only represent around 10% of CRISPR-Cas systems for use in human cells. The reason for the focus on them is because they have been deemed simpler to work with.

While some revolutionary developments have been made with class 2, the scientists were inspired to look into class 1 CRISPR-Cas systems to see if they could get them to work in human cells similar to how Cas9 works.

Could we use class 1 systems to edit the human genome?

Class 1 systems are more complex than class 2; they rely on numerous proteins in harmony within a cascade (CRISPR-associated complex for antiviral defense). In fact, 90 percent of bacteria use the class 1 system, making it a significant font of potential biotechnology tools.

The Duke team recognized this untapped potential and have demonstrated CRISPR class 1’s potential through their recent research. Their research saw gene activators attached to specific sites on a type I E. coli cascade complex. The researchers then targeted the system to bind gene promoters.

The results of the experiment showed that through targeting to these gene promotors, gene expression levels could be controlled for. They found they could increase the levels of a target gene or go the opposite way and switch it off.

The findings show that class 1 mechanisms have to ability to edit human DNA with a similar impact to Cas-9 systems, but without cutting, adding or removing genetic information.

The future looks bright

The researchers at Duke have opened up a world of possibility for developing new gene-editing tools. No longer restricted to focussing on Cas-9, the team have demonstrated that class 1 systems can be manipulated to edit human DNA in different ways but with similar impact.

At present, the team has merely shown that the class 1 systems are compatible to Cas-9, the future will see the exploration of how these systems are beneficially different, and what biotechnology applications could be developed from them.

The team will now look into potential therapeutic applications. It is clear that the full potential of CRISPR is still unknown, and applications outside of this area still need to be explored.

Journal reference:

Pickar-Oliver, A., et al. (2019).Targeted transcriptional modulation with type I CRISPR–Cas systems in human cells. Nature Biotechnology.

Sarah Moore

Written by

Sarah Moore

After studying Psychology and then Neuroscience, Sarah quickly found her enjoyment for researching and writing research papers; turning to a passion to connect ideas with people through writing.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Moore, Sarah. (2019, September 23). CRISPR discovery opens up new possibilities for genetic engineering. News-Medical. Retrieved on December 10, 2019 from https://www.news-medical.net/news/20190923/CRISPR-discovery-opens-up-new-possibilities-for-genetic-engineering.aspx.

  • MLA

    Moore, Sarah. "CRISPR discovery opens up new possibilities for genetic engineering". News-Medical. 10 December 2019. <https://www.news-medical.net/news/20190923/CRISPR-discovery-opens-up-new-possibilities-for-genetic-engineering.aspx>.

  • Chicago

    Moore, Sarah. "CRISPR discovery opens up new possibilities for genetic engineering". News-Medical. https://www.news-medical.net/news/20190923/CRISPR-discovery-opens-up-new-possibilities-for-genetic-engineering.aspx. (accessed December 10, 2019).

  • Harvard

    Moore, Sarah. 2019. CRISPR discovery opens up new possibilities for genetic engineering. News-Medical, viewed 10 December 2019, https://www.news-medical.net/news/20190923/CRISPR-discovery-opens-up-new-possibilities-for-genetic-engineering.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Experts condemn CRISPR babies research as original manuscript is made public